Literature DB >> 8232506

Interferon alfa plus chemotherapy for non-Hodgkin's lymphoma: five-year follow-up.

J W Andersen, R V Smalley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8232506     DOI： 10.1056/NEJM199312093292419

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691.

Authors:  S M Smith; J Johnson; B D Cheson; G Canellos; G Petroni; M Oken; D Duggan; D Hurd; J P Gockerman; B Parker; J Prchal; B A Peterson
Journal:  Leuk Lymphoma       Date:  2009-10

Review 2.  Cytokines in the pathophysiology and treatment of chronic B-cell malignancies. A review.

Authors:  M Schuler; C Huber; C Peschel
Journal:  Ann Hematol       Date:  1995-08       Impact factor: 3.673

3.  A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma.

Authors:  A Rohatiner; J Radford; D Deakin; H Earl; S B Love; O Price; A Wilson; T A Lister
Journal:  Br J Cancer       Date:  2001-07-06       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.